DOI: 10.1055/s-00000099

Zeitschrift für Orthopädie und Unfallchirurgie


Cherian JJ, Parvizi J, Bramlet D. et al.
Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-beta1 in patients with grade 3 chronic degenerative joint disease of the knee.

Osteoarthritis Cartilage 2015;
23: 2109-2118

Download Bibliographical Data

Search in: